Implanet SA (ALIMP) - Total Assets
Based on the latest financial reports, Implanet SA (ALIMP) holds total assets worth €18.45 Million EUR (≈ $21.57 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Implanet SA (ALIMP) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Implanet SA - Total Assets Trend (2010–2025)
This chart illustrates how Implanet SA's total assets have evolved over time, based on quarterly financial data. Explore ALIMP long-term investments to assets to see how much of total assets are deployed in long-term investments.
Implanet SA - Asset Composition Analysis
Current Asset Composition (December 2025)
Implanet SA's total assets of €18.45 Million consist of 74.5% current assets and 25.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 16.3% |
| Accounts Receivable | €3.21 Million | 17.4% |
| Inventory | €7.01 Million | 38.0% |
| Property, Plant & Equipment | €2.02 Million | 11.0% |
| Intangible Assets | €2.58 Million | 14.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2010–2025)
This chart illustrates how Implanet SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ALIMP market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Implanet SA's current assets represent 74.5% of total assets in 2025, an increase from 0.0% in 2010.
- Cash Position: Cash and equivalents constituted 16.3% of total assets in 2025, up from 9.2% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 38.0% of total assets.
Implanet SA Competitors by Total Assets
Key competitors of Implanet SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Inspire Medical Systems Inc
NYSE:INSP
|
USA | $911.38 Million |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥1.59 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
|
Scandinavian Medical Solutions AS
CO:SMSMED
|
Denmark | Dkr205.86 Million |
|
Duearity AB
ST:DEAR
|
Sweden | Skr10.84 Million |
Implanet SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.80 | 0.85 | 1.50 |
| Quick Ratio | 0.39 | 0.38 | 0.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-3.46 Million | €-1.89 Million | €2.33 Million |
Implanet SA - Advanced Valuation Insights
This section examines the relationship between Implanet SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 65.50 |
| Latest Market Cap to Assets Ratio | 1.53 |
| Asset Growth Rate (YoY) | 23.9% |
| Total Assets | €18.45 Million |
| Market Capitalization | $28.16 Million USD |
Valuation Analysis
Above Book Valuation: The market values Implanet SA's assets above their book value (1.53x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Implanet SA's assets grew by 23.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Implanet SA (2010–2025)
The table below shows the annual total assets of Implanet SA from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €18.45 Million ≈ $21.57 Million |
+23.89% |
| 2024-12-31 | €14.89 Million ≈ $17.41 Million |
+39.98% |
| 2023-12-31 | €10.64 Million ≈ $12.44 Million |
-26.51% |
| 2022-12-31 | €14.47 Million ≈ $16.92 Million |
-13.34% |
| 2021-12-31 | €16.70 Million ≈ $19.53 Million |
+91.96% |
| 2020-12-31 | €8.70 Million ≈ $10.17 Million |
-9.82% |
| 2019-12-31 | €9.65 Million ≈ $11.28 Million |
+9.04% |
| 2018-12-31 | €8.85 Million ≈ $10.35 Million |
-29.56% |
| 2017-12-31 | €12.56 Million ≈ $14.69 Million |
-23.67% |
| 2016-12-31 | €16.46 Million ≈ $19.24 Million |
+1.03% |
| 2015-12-31 | €16.29 Million ≈ $19.04 Million |
+11.92% |
| 2014-12-31 | €14.55 Million ≈ $17.02 Million |
-39.16% |
| 2013-12-31 | €23.92 Million ≈ $27.97 Million |
+103.23% |
| 2012-12-31 | €11.77 Million ≈ $13.76 Million |
-29.58% |
| 2011-12-31 | €16.72 Million ≈ $19.54 Million |
+42.02% |
| 2010-12-31 | €11.77 Million ≈ $13.76 Million |
-- |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-… Read more